STARD Checklist & Reporting Guide
Use this structured template and monitoring guide to align your diagnostic accuracy research with the STARD (Standards for Reporting Diagnostic Accuracy) statement. This utility serves as an essential framework for medical researchers, clinical pathologists, and academic authors to ensure absolute transparency, clarity, and completeness when publishing studies that evaluate the performance of a medical test.
The Purpose and Importance of the STARD Statement
The STARD statement is an evidence-based, minimum set of recommendations designed to improve the completeness and transparency of reports on diagnostic accuracy studies. In clinical medicine, before a new diagnostic test, imaging modality, or laboratory biomarker can be safely integrated into practice, its accuracy must be rigorously compared against an established benchmark.
If a diagnostic study fails to report how patients were selected, how the tests were conducted, or how borderline results were handled, clinicians cannot reliably determine the true clinical utility of the test. STARD addresses this issue by forcing authors to disclose the complete layout of their study design, helping peer reviewers and clinicians detect potential selection bias, verification bias, or spectrum bias.
The STARD Checklist Core Sections
The STARD framework relies on a highly structured checklist that covers every critical section of a medical manuscript:
Title & Abstract: Explicit identification that the study evaluates and compares the diagnostic accuracy of one or more medical tests.
Introduction: Detailed clinical and scientific background, including the intended clinical use and position of the index test in the diagnostic pathway, followed by specific research objectives.
Methods: This section demands complete procedural details. Authors must specify the study population, participant recruitment dates, eligibility criteria, and how the clinical setting reflects real-world practice. Crucially, it requires explicit definitions of both the Index Test (the test under evaluation) and the Reference Standard (the best available "gold standard" verification test). It also demands full disclosure of whether the professionals interpreting the tests were blinded to other clinical data.
Results: A detailed accounting of participant flow, including the baseline demographic and clinical characteristics of the sample. Authors must report the exact distribution of disease severity, the number of indeterminate or uninterpretable test results, and any adverse events caused by the testing procedures.
Discussion: A balanced clinical interpretation of the findings, outlining study limitations, potential biases, and generalizability to broader patient populations.
Other Information: Clinical trial registration details, protocol availability, and explicit funding disclosures.
Key Diagnostic Metrics to Report under STARD
When publishing diagnostic research, presenting raw numbers alongside standard statistical metrics is mandatory for clear clinical interpretation:
Sensitivity: The probability that the index test will correctly identify a patient who truly has the target condition (True Positive Rate).
Specificity: The probability that the index test will correctly identify a patient who does not have the target condition (True Negative Rate).
Positive Predictive Value (PPV): The probability that a patient truly has the disease given that their test result is positive. This value shifts significantly based on the prevalence of the condition in the study population.
Negative Predictive Value (NPV): The probability that a patient is truly free of the disease given that their test result is negative.
Likelihood Ratios (LR): Both positive and negative likelihood ratios should be reported. These metrics indicate how much a given test result raises or lowers the pre-test probability of a specific disease, providing direct utility at the bedside.
STARD Statement References
Bossuyt, P. M., Reitsma, J. B., Bruns, D. E., et al. (2015). STARD 2015: an updated list of essential items for reporting diagnostic accuracy studies. BMJ, 351, h5527.
Cohen, J. F., Korevaar, D. A., Altman, D. G., et al. (2016). STARD 2015 explanation and elaboration: updated guidelines for reporting diagnostic accuracy studies. BMJ Open, 6(1), e012799.
Bossuyt, P. M., Reitsma, J. B., Bruns, D. E., et al. (2003). Towards complete and accurate reporting of studies of diagnostic accuracy: The STARD Statement. Annals of Internal Medicine, 138(1), 40-44.
Got any Suggestion?
Contact:
info@histamind.com